Remote Patient Monitoring (RPM) Market: By Type (Heart Monitors, Breath Monitors, Hematology Monitors, Multi-parameter Monitors, and Other); By Application (Cancer Treatment, Cardiovascular Diseases, Diabetes Treatment, Sleep Disorder, Weight Managem

SKU ID :FPG-19068764 | Published Date: 05-Sep-2021 | No. of pages: 95
Contents 1. Executive Summary 2. Remote Patient Monitoring (RPM) Market 2.1. Product Overview 2.2. Market Definition 2.3. Segmentation 2.4. Assumptions and Acronyms 3. Research Methodology 3.1. Research Objectives 3.2. Primary Research 3.3. Secondary Research 3.4. Forecast Model 3.5. Market Size Estimation 4. Average Pricing Analysis 5. Macro-Economic Indicators 6. Market Dynamics 6.1. Growth Drivers 6.2. Restraints 6.3. Opportunity 6.4. Trends 7. Correlation & Regression Analysis 7.1. Correlation Matrix 7.2. Regression Matrix 8. Recent Development, Policies & Regulatory Landscape 9. Risk Analysis 9.1. Demand Risk Analysis 9.2. Supply Risk Analysis 10. Remote Patient Monitoring (RPM) Analysis 10.1. Porters Five Forces 10.1.1. Threat of New Entrants 10.1.2. Bargaining Power of Suppliers 10.1.3. Threat of Substitutes 10.1.4. Rivalry 10.2. PEST Analysis 10.2.1. Political 10.2.2. Economic 10.2.3. Social 10.2.4. Technological 11. Remote Patient Monitoring (RPM) Market 11.1. Market Size & forecast, 2019A-2030F 11.1.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 11.1.2. By Volume (Million Units) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 12. Remote Patient Monitoring (RPM): Market Segmentation 12.1. By Regions 12.2. By Regions 12.2.1. North America:(U.S. and Canada) • By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 12.2.2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America) • By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 12.2.3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe) • By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 12.2.4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific) • By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 12.2.5. Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of Middle East and Africa) • By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F s12.2. By Type: Market Share (2020-2030F) 12.2.1. Heart Monitors, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 12.2.2. Breath Monitors, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 12.2.3. Hematology Monitors, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 12.2.4. Multi-parameter Monitors, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 12.2.5. Other, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 12.3 By Application: Market Share (2020-2030F) 12.3.1. Cancer Treatment, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 12.3.2. Cardiovascular Diseases, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 12.3.3. Diabetes Treatment, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 12.3.4. Weight Management and Fitness Monitoring, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 12.3.5. Sleep Disorder, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 12.3.6. Others, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 12.4. By Type: Market Share (2020-2030F) 12.4.1. Home Care Settings, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 12.4.2. Hospital/Clinics, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 12.2.3. Other, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 13. Company Profile 13.1.1. Abbott Laboratories 13.1.2. Company Overview 13.1.3. Company Total Revenue (Financials) 13.1.4. Market Potential 13.1.5. Global Presence 13.1.6. Key Performance Indicators 13.1.7. SWOT Analysis 13.1.8. Product Launch 13.2. Aerotel Medical Systems 13.3. AMD Global Telemedicine 13.4. Baxter International Inc. 13.5. Boston Scientific Corporation 13.6. GE Healthcare 13.7. Masimo Corporation 13.8. Medtronic PLC 13.9. Omron Corporation 14 Consultant Recommendation **The above given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.
  • PRICE
  • $5000
    $10000

Our Clients